Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT04513717 |
Title | Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial |
Recruitment | Recruiting |
Gender | male |
Phase | Phase III |
Variant Requirements | No |
Sponsors | NRG Oncology |
Indications | |
Therapies |
Abiraterone + Apalutamide + Degarelix + Prednisone Abiraterone + Apalutamide + Buserelin + Prednisone Abiraterone + Apalutamide + Leuprolide + Prednisone Abiraterone + Apalutamide + Histrelin acetate + Prednisone Abiraterone + Apalutamide + Goserelin + Prednisone |
Age Groups: | adult | senior |
Covered Countries | USA |